Drug Overview: Flutiform

Drug Overview: Flutiform

  • February 2018 •
  • 17 pages •
  • Report ID: 5391446 •
  • Format: PDF
Drug Overview
Flutiform ([fluticasone propionate + formoterol fumarate]; Vectura/Mundipharma/Kyorin) is a pressurized metered-dose inhaler formulation which contains a combination of fluticasone propionate and formoterol. Fluticasone propionate is an inhaled corticosteroid which has potent anti-inflammatory activity when delivered by inhalation, while formoterol fumarate is a long-acting beta 2 agonist which acts as a bronchodilator.